Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 105Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College

Khandeparkar Akshay, Rataboli Padmanabh V

Year : 2017| Volume: 8| Issue : 4 | Page no: 180-186

   This article has been cited by
 
1 Simultaneous Pharmacokinetic Evaluation of Pantoprazole and Vitamin B Complex for Assessing Drug–Drug Interactions in Healthy Bangladeshi Adults by a Newly Developed and Validated HPLC Method
Sherejad Sanam, Shimul Halder, S. M. Abdur Rahman
Separations. 2023; 10(3): 170
[Pubmed]  [Google Scholar] [DOI]
2 Abnormal liver function test in patients with diabetes and hypertension on treatment at the Laquintinie and Douala General Hospitals
Kenfack Fidele, Shey Nsagha Dickson, Clement Assob Jules
Journal of Public Health and Epidemiology. 2022; 14(4): 160
[Pubmed]  [Google Scholar] [DOI]
3 Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States
Maria Fleseriu, Ariel Barkan, Maria del Pilar Schneider, Yannis Darhi, Amicie de Pierrefeu, Antonio Ribeiro-Oliveira, Stephan Petersenn, Sebastian Neggers, Shlomo Melmed
Pituitary. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Association between polypharmacy and mortality in the older adults: A systematic review and meta-analysis
Yuan Li, Xianzhuo Zhang, Liu Yang, Yongjie Yang, Gaoxing Qiao, Chunyun Lu, Kefeng Liu
Archives of Gerontology and Geriatrics. 2022; 100: 104630
[Pubmed]  [Google Scholar] [DOI]
5 Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting
Darach Ó Ciardha, Anne-Marie Blake, Dylan Creane, Michael Ó Callaghan, Catherine Darker
BMJ Open. 2022; 12(5): e050261
[Pubmed]  [Google Scholar] [DOI]
6 Identification of Potential of Drug-drug Interaction and its Affecting Factors: A Cross-sectional Study Among Hospitalized Coronary Heart Disease Patients
Reny Rosmasari, Pramitha Esha, Albert Figueras
Current Drug Therapy. 2022; 17(2): 108
[Pubmed]  [Google Scholar] [DOI]
7 Recent Updates on Risk and Management Plans Associated with Polypharmacy in Older Population
Asim Muhammed Alshanberi
Geriatrics. 2022; 7(5): 97
[Pubmed]  [Google Scholar] [DOI]
8 Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
Malavika Deodhar,Sweilem B. Al Rihani,Lucy Darakjian,Jacques Turgeon,Veronique Michaud
Pharmaceutics. 2021; 13(2): 148
[Pubmed]  [Google Scholar] [DOI]
9 The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland
Przemyslaw Kardas,Filip Urbanski,Aneta Lichwierowicz,Ewa Chudzynska,Marcin Czech,Katarzyna Makowska,Grzegorz Kardas
Frontiers in Pharmacology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
10 Prevalence, Incidence, and Characteristics of Adverse Drug Reactions Among Older Adults Hospitalized at Mbarara Regional Referral Hospital, Uganda: A Prospective Cohort Study
Tadele Mekuriya Yadesa,Freddy Eric Kitutu,Robert Tamukong,Paul E Alele
Clinical Interventions in Aging. 2021; Volume 16: 1705
[Pubmed]  [Google Scholar] [DOI]
11 Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data
Levin Thomas, Sumit Raosaheb Birangal, Rajdeep Ray, Sonal Sekhar Miraj, Murali Munisamy, Muralidhar Varma, Chidananda Sanju S.V., Mithu Banerjee, Gautham G. Shenoy, Mahadev Rao
Therapeutic Advances in Drug Safety. 2021; 12: 2042098621
[Pubmed]  [Google Scholar] [DOI]
12 Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: A systematic review and meta-analysis
Tadele Mekuriya Yadesa, Freddy Eric Kitutu, Serawit Deyno, Patrick Engeu Ogwang, Robert Tamukong, Paul E Alele
SAGE Open Medicine. 2021; 9: 2050312121
[Pubmed]  [Google Scholar] [DOI]
13 On the robustness of generalization of drug–drug interaction models
Rogia Kpanou,Mazid Abiodoun Osseni,Prudencio Tossou,Francois Laviolette,Jacques Corbeil
BMC Bioinformatics. 2021; 22(1)
[Pubmed]  [Google Scholar] [DOI]
14 Potential drug interactions in adults living in the Brazilian Amazon: A population-based case-control study, 2019
Tayanny Margarida Menezes Almeida Biase,Marcus Tolentino Silva,Tais Freire Galvao
Exploratory Research in Clinical and Social Pharmacy. 2021; : 100056
[Pubmed]  [Google Scholar] [DOI]
15 A Rare Case of Delayed Onset Multi-Drug Interaction Resulting in Rhabdomyolysis in a 66-Year-Old Male
Harmony Osborn, Daniel Grossman, Smriti Kochhar, Anish Kanukuntla, Priyaranjan Kata, Pramil Cheriyath
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
16 Issues and challenges of polypharmacy in the elderly: A review of contemporary Indian literature
Abhik Sinha, Shatavisa Mukherjee, Santanu Tripathi, Shanta Dutta
Journal of Family Medicine and Primary Care. 2021; 10(10): 3544
[Pubmed]  [Google Scholar] [DOI]
17 Critical Care Pharmacist Using Free Drug-Interaction Checker Mobile Apps Can Ensure Medication Safety in Critically Ill Patients
Md Jahidul Hasan,Raihan Rabbani,Sitesh C Bachar
Jundishapur Journal of Health Sciences. 2020; In Press(In Press)
[Pubmed]  [Google Scholar] [DOI]
18 Frequency and risk factors of polypharmacy and drug interactions among patients in general intensive care unit of Golestan Hospital, Ahvaz, southwest of Iran
Mobina Tahmasebivand,Farhad Soltani,Leila Kouti,Mandana Izadpanah
AIMS Medical Science. 2020; 7(2): 69
[Pubmed]  [Google Scholar] [DOI]
19 Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Morgan A Wambaugh,Steven T Denham,Magali Ayala,Brianna Brammer,Miekan A Stonhill,Jessica CS Brown
eLife. 2020; 9
[Pubmed]  [Google Scholar] [DOI]
20 Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
Gayathri Baburaj,Levin Thomas,Mahadev Rao
Archives of Medical Research. 2020;
[Pubmed]  [Google Scholar] [DOI]
21 Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?
Emre Kara,Aygin Bayraktar Ekincioglu,Gokhan Metan
Antimicrobial Agents and Chemotherapy. 2020; 65(2)
[Pubmed]  [Google Scholar] [DOI]
22 Potential drug-drug interactions in ICU patients: a retrospective study
Iyad Ali,Alaa Bazzar,Nadine Hussein,Emile Sahhar
Drug Metabolism and Personalized Therapy. 2020; 0(0)
[Pubmed]  [Google Scholar] [DOI]
23 The Relationship Between Polypharmacy and Muscle Strength and Function in Hospitalized Elderly Patients
Remzi Bahsi,Hande Selvi Öztorun,Tugba Turgut,Deniz Mut Sürmeli,Çaglar Kosarderelioglu,Volkan Atmis,Sevgi Aras,Murat Varli
Ankara Medical Journal. 2019;
[Pubmed]  [Google Scholar] [DOI]
24 Yogun Bakim Hastalarinda Antibiyotiklerin Diger Ilaçlarla Etkilesimlerinin Degerlendirilmesi
EMRE KARA,Kamer Tecen-Yücel,Nesligül Özdemir,Ahmet Çagkan Inkaya,Aygin Bayraktar-Ekincioglu,Kutay Demirkan,Serhat Ünal
STED / Sürekli Tip Egitimi Dergisi. 2019; : 404
[Pubmed]  [Google Scholar] [DOI]
25 Incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia
Nusrat Khan,Kaushik Chattopadhyay,Jo Leonardi-Bee
JBI Database of Systematic Reviews and Implementation Reports. 2019; 17(11): 2370
[Pubmed]  [Google Scholar] [DOI]
26 Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study
Fernanda Raphael Escobar Gimenes,Melissa Baysari,Scott Walter,Leticia Alves Moreira,Rhanna Emanuela Fontenele Lima de Carvalho,Adriana Inocenti Miasso,Fabiana Faleiros,Johanna Westbrook,Shane Patman
PLOS ONE. 2019; 14(7): e0220248
[Pubmed]  [Google Scholar] [DOI]
27 The prevalence of potentially beneficial and harmful drug-drug interactions in intensive care units
Hossein Ali Mehralian,Jafar Moghaddasi,Hossein Rafiei
Drug Metabolism and Personalized Therapy. 2019; 34(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article